Sinphar Pharmaceutical Co.,Ltd. (TPE:1734)

Sinphar Pharmaceutical Revenue

Sinphar Pharmaceutical had revenue of 826.63M TWD in the quarter ending March 31, 2026, with 2.61% growth. This brings the company's revenue in the last twelve months to 3.39B, up 6.72% year-over-year. In the year 2025, Sinphar Pharmaceutical had annual revenue of 3.37B with 7.00% growth.

• Revenue (ttm): 3.39B
• Revenue Growth: +6.72%
• P/S Ratio: 1.72
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.84B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	3.37B	220.69M	7.00%
Dec 31, 2024	3.15B	187.69M	6.33%
Dec 31, 2023	2.96B	106.28M	3.72%
Dec 31, 2022	2.86B	423.14M	17.39%
Dec 31, 2021	2.43B	45.06M	1.89%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 29, 2026

Data Sources Report a data error